Minimally Invasive Micro Sclerostomy: Performance and Safety Evaluation Study

Eligible patients will have ECG and blood test up to 30 days prior to the MIMS procedure. Description of MIMS procedure: on surgery day, intraocular pressure (IOP) will be measured. Then a sub-conjunctival injection of Mitomycin C will be administered . creating drainage channel at the sclera-corneal junction by penetrating through the wall \[scleral tissue\]. MIMS procedure may be combined with cataract surgery. Post-operatively the patient will be treated with dexamethasone-neomycin drops for at least one month. Patients will be followed up to 52 weeks post operation. The following measurements will be included: * Intra Ocular Pressure (IOP) * Best Corrected Visual Acuity (BCVA) * Slit Lamp Biomicroscopic evaluation * Anterior Segment Optical coherence tomography (OCT) * Fundus Examination